These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 18989859

  • 21. Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
    Liang GB, Qian X, Feng D, Biftu T, Eiermann G, He H, Leiting B, Lyons K, Petrov A, Sinha-Roy R, Zhang B, Wu J, Zhang X, Thornberry NA, Weber AE.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):1903-7. PubMed ID: 17291750
    [Abstract] [Full Text] [Related]

  • 22. [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.
    Yoshida T, Sakashita H, Akahoshi F, Hayashi Y.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2618-21. PubMed ID: 17317162
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitors.
    Wang L, Zhang B, Ji J, Li B, Yan J, Zhang W, Wu Y, Wang X.
    Eur J Med Chem; 2009 Aug 01; 44(8):3318-22. PubMed ID: 19375196
    [Abstract] [Full Text] [Related]

  • 24. Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors.
    Tsai TY, Hsu T, Chen CT, Cheng JH, Chiou MC, Huang CH, Tseng YJ, Yeh TK, Huang CY, Yeh KC, Huang YW, Wu SH, Wang MH, Chen X, Chao YS, Jiaang WT.
    Bioorg Med Chem Lett; 2009 Apr 01; 19(7):1908-12. PubMed ID: 19269819
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Ahn JH, Shin MS, Jun MA, Jung SH, Kang SK, Kim KR, Rhee SD, Kang NS, Kim SY, Sohn SK, Kim SG, Jin MS, Lee JO, Cheon HG, Kim SS.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2622-8. PubMed ID: 17331715
    [Abstract] [Full Text] [Related]

  • 28. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.
    Nordhoff S, Cerezo-Gálvez S, Deppe H, Hill O, López-Canet M, Rummey C, Thiemann M, Matassa VG, Edwards PJ, Feurer A.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4201-3. PubMed ID: 19515557
    [Abstract] [Full Text] [Related]

  • 29. Affinity-based ranking of ligands for DPP-4 from mixtures.
    Adam GC, Meng J, Athanasopoulos J, Zhang X, Chapman KT.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2404-7. PubMed ID: 17337342
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
    Almasri IM, Taha MO, Mohammad MK.
    Arch Pharm Res; 2013 Nov 01; 36(11):1326-37. PubMed ID: 23918649
    [Abstract] [Full Text] [Related]

  • 32. Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).
    Paliwal S, Seth D, Yadav D, Yadav R, Paliwal S.
    J Enzyme Inhib Med Chem; 2011 Feb 01; 26(1):129-40. PubMed ID: 21299434
    [Abstract] [Full Text] [Related]

  • 33. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D, Jin F, Lu W, Zhu J, Li C, Wang W, Tang Y, Jiang H, Huang J, Liu G, Li J.
    Chem Biol Drug Des; 2012 Jun 01; 79(6):897-906. PubMed ID: 22381062
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Discovery of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl transferase inhibitors followed by in silico screening.
    Taha MO, Qandil AM, Al-Haraznah T, Khalaf RA, Zalloum H, Al-Bakri AG.
    Chem Biol Drug Des; 2011 Sep 01; 78(3):391-407. PubMed ID: 21679375
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors.
    Park WS, Kang SK, Jun MA, Shin MS, Kim KY, Rhee SD, Bae MA, Kim MS, Kim KR, Kang NS, Yoo SE, Lee JO, Song DH, Silinski P, Schneider SE, Ahn JH, Kim SS.
    Bioorg Med Chem Lett; 2011 Mar 01; 21(5):1366-70. PubMed ID: 21306895
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.